CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Yehia Hashad

Executive Vice President of R&D and Chief Medical Officer, Bausch + Lomb Corporation

Verified interview transcripts, podcast appearances, and direct quotes from Yehia Hashad, Executive Vice President of R&D and Chief Medical Officer at Bausch + Lomb Corporation. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • Bausch + Lomb Corporation R&D Day 2026 | June 01, 2026

    June 05, 2026 · 📺 Investing 101

    Bausch + Lomb Corporation R&D Day 2026 | June 01, 2026. Twitter -   / i101in   If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news | Annual Meeting of Shareholders | Annual Meeting of Unitholders | Special and Annual Meeting of Shareholders | AGM | Annual General Meeting If you want us to remove your company's ea…

    Watch on YouTube ↗

  • Bausch + Lomb Corporation R&D “Teach in” Webinar | March 23, 2026

    March 24, 2026 · 📺 Investing 101

    Bausch + Lomb Corporation R&D “Teach in” Webinar | March 23, 2026. Twitter -   / i101in   If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • OIS Podcast Ep #380: The Bausch + Lomb Buzz, with Andrew Stewart and Yehia Hashad, MD

    October 06, 2023 · 📺 OIS: Ophthalmology Innovation Source

    “You can see and feel a buzz within the company right now,” said Andrew Stewart, President, Global Pharmaceuticals and International Consumer, at Bausch + Lomb. Bausch + Lomb’s current momentum stems not only from new leadership, but also from recent collaborations, partnerships, and acquisitions. Stewart and Yehia Hashad, MD, Executive Vice President of Research & Development and Chief Medical Officer, join host Paul Karpecki, OD, to discuss these activities. Miebo, the first-in-class dry eye asset for the treatment of evaporative dry eye, tops the list. Looking ahead, Stewart and Dr. Hash…

    Watch on YouTube ↗

Other executives at Bausch + Lomb Corporation

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →